(Q44376284)

2 December 2017

title

Oxcarbazepine in the treatment of childhood epilepsy (English)

1 reference

2 December 2017

Gul Serdaroglu

1

1 reference

2 December 2017

Semra Kurul

2

1 reference

2 December 2017

Sarenur Tutuncuoglu

3

1 reference

2 December 2017

Eray Dirik

4

1 reference

2 December 2017

Berrak Sarioglu

5

1 reference

2 December 2017

publication date

1 January 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

28

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

37-41

1 reference

Clinical pharmacology and pharmacokinetics of oxcarbazepine

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

Voltage-activated calcium channels: targets of antiepileptic drug therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

Monotherapy trials of new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

New antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

Oxcarbazepine: an update of its efficacy in the management of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

Oxcarbazepine in the treatment of early childhood epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

Oxcarbazepine versus carbamazepine treatment and induction of serum lipid abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900467-8

1 reference

7 January 2021

10.1016/S0887-8994(02)00467-8

Identifiers

DOI

1 reference

2 December 2017

1 reference